Analysis of minimum inhibitory concentrations of azithromycin, ceftriaxone and ciprofloxacin for Neisseria gonorrhoeae from antimicrobial resistance sentinel surveillance, Germany, 2014 to 2023
Open Access
- 27 August 2026
- journal article
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 31 (34) , 2500803
Abstract
BACKGROUND: Neisseria gonorrhoeae (NG), the pathogen causing the sexually transmitted infection (STI) gonorrhoea, shows increasing antimicrobial resistance threatening recommended treatments. AIM: We examined temporal trends in antibiotic susceptibility of NG isolates in Germany and possible shifts in sexual networks. METHODS: We analysed annual data from the German antimicrobial resistance sentinel surveillance programme Go-Surv-AMR (2014–2023). Isolates were tested by E-test for phenotypic susceptibility to azithromycin (AZM), ceftriaxone (CRO) and ciprofloxacin (CIP) to determine minimum inhibitory concentrations (MIC). We described patient demographics and calculated MIC metrics by year, sex, age group and specimen type. We assessed differences in yearly MIC distributions using Kolmogorov-Smirnov tests and analysed temporal trends by fitting beta distributions to log-transformed MIC by antibiotic and epidemiological group. RESULTS: We collected 5,421 NG isolates from across Germany, primarily from males (n = 4,704) and from urethral specimens (n = 4,060). From 2016 to 2023, median AZM MIC nearly quadrupled in female and male isolates (0.12–0.45 mg/L). Median CRO MIC remained low overall (≤ 0.009 mg/L) but increased significantly in males in 2022–2023, especially in extragenital/screening isolates. Median CIP MIC increased (0.003–0.0057 mg/L), most pronounced in male extragenital/screening isolates. CONCLUSION: Across the examined decade, NG showed subtle increases in MIC in extragenital/screening isolates from males, possibly reflecting decreasing antibiotic susceptibility in groups that regularly undergo STI screening. Rising AZM MIC suggests early spread of resistant strains. This highlights the need for continued surveillance, consistent susceptibility testing, targeted education for vulnerable groups, promotion of condom use, and potential vaccination.Keywords
This publication has 15 references indexed in Scilit:
- Antimicrobial-Resistant Neisseria gonorrhoeae Infections in Men Using Doxycycline Postexposure Prophylaxis: A Substudy of the ANRS 174 DOXYVAC TrialClinical Infectious Diseases, 2025
- Doxy-PEP could select for ceftriaxone resistance in Neisseria gonorrhoeaeThe Lancet Infectious Diseases, 2025
- Antimicrobial treatment and resistance in sexually transmitted bacterial infectionsNature Reviews Microbiology, 2024
- Recent insights suggest the need for the STI field to embrace a more eco-social conceptual framework: A viewpointInternational Journal of STD & AIDS, 2022
- The Mosaic mtr Locus as Major Genetic Determinant of Azithromycin Resistance of Neisseria gonorrhoeae—Germany, 2018The Journal of Infectious Diseases, 2021
- Epidemiology of gonorrhoea: a global perspectiveSexual Health, 2019
- Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014–2016The Journal of Infectious Diseases, 2019
- Azithromycin Resistance through Interspecific Acquisition of an Epistasis-Dependent Efflux Pump Component and Transcriptional Regulator in Neisseria gonorrhoeaemBio, 2018
- Data Analysis2016
- Extragenital Infections Caused byChlamydia trachomatisandNeisseria gonorrhoeae: A Review of the LiteratureInfectious Diseases in Obstetrics and Gynecology, 2016